BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1
Clinical Trials Related to HER2-negative Breast Cancer
Related studies linked through entity extraction aliases.
Organoid-based Functional Precision Therapy for Advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Study of Predictors of Clinical Outcomes in Patients With HR+ and HER2-low/Negative Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate Biomarkers and Safety of Dapagliflozin Concomitant With Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- PHASE1
Elacestrant With/Without Triptorelin in Premenopausal Women With Luminal Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Phase I Clinical Trials Investigating the Potential Efficacy of Axitinib in Patients With a BRCA 1/2 Mutations
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Concomitant Modulated Electro-hyperthermia in HER2-negative Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2/PHASE3
CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective Registry - Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
PRE-I-SPY Phase I/Ib Oncology Platform Program
- Status
- RECRUITING
- Phase
- PHASE1
Levels of Circulating Tumor DNA as a Predictive Marker for Early Switch in Treatment for Patients With Metastatic (Stage IV) Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
First-in-Human Study of RLY-5836 in Advanced Breast Cancer and Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Alpelisib/iNOS Inhibitor/Nab-paclitaxel in Patients With HER2 Negative Metaplastic Breast Cancer (MpBC)
- Status
- RECRUITING
- Phase
- PHASE2
(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Anastrazole, Fulvestrant & Abemaciclib for HR+HER2- Metastatic Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Elacestrant for Treating ER+/HER2- Breast Cancer Patients With ctDNA Relapse (TREAT ctDNA)
- Status
- RECRUITING
- Phase
- PHASE3
Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
- Status
- RECRUITING
- Phase
- PHASE1
Fasting Mimicking Diet Program to ImpRovE ChemoTherapy in Hormone Receptor Postive (HR+), HER2- Breast Cancer
- Status
- SUSPENDED
- Phase
- PHASE3